Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR

Neuropathology and Applied Neurobiology

Volumn 35, Issue 1, 2009, Pages 103-110

  Martignago, S ^a   Fanin, M ^a,b   Albertini, E ^a   Pegoraro, E ^a   Angelini, C ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

AChR; Antibodies; Muscle biopsy; Muscle specific tyrosin kinase; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CYTOCHROME C OXIDASE; MUSCLE PROTEIN; MUSK ANTIBODY; PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BULBAR PARALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRIAL MEMBRANE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MUSCULAR ATROPHY; MYASTHENIA GRAVIS; NADH TETRAZOLIUM REDUCTASE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 58849112628     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2008.00965.x     Document Type: Article

References (29)

1. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinets E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD. The receptor tyrosin kinase MuSK is required for neuromuscolar junction formation in vivo. Cell 1996 85 : 501 12
2. Hoch W, McConville J, Helms J, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosin-kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001 7 : 365 8
3. Benveniste O, Jacobson L, Farrugia ME, Clover L, Vincent A. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscles in vivo. J Neuroimmunol 2005 120 : 41 8
4. Selcen D, Fukuda T, Shen XM, Engel AG. Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 2004 62 : 1945 50
5. Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 2007 185 : 136 44
6. Bartoccioni E, Scuderi F, Minicuci GM, Marino M, Ciaraffa F, Evoli A. Anti-MuSK antibodies: correlation with myasthenia gravis severity. Neurology 2006 67 : 505 7
7. Stickler DE, Massey JM, Sanders DB. MuSK- antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 2005 116 : 2065 8
8. Lavrnic D, Losen M, Vujic A, De Baets M, Haidukowic LJ, Stojanovic V, Trikic R, Djukic P, Apostolski S. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 2005 76 : 1099 102
9. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003 126 : 2304 11
10. Caress JB, Hunt CH, Batish SD. Anti-Mu SK myasthenia gravis presenting with purely ocular findings. Arch Neurol 2005 62 : 1002 3
11. Hain B, Hanisch F, Deschauer M. Seronegative myasthenia with antibodies against muscle-specific tyrosin kinase. Nervenartz 2004 75 : 362 7
12. Vincent A, Leite MI. Neuromuscolar junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005 18 : 519 25
13. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their target. Lancet Neurol 2003 2 : 99 106
14. Xu K, Jha S, Hoch W, Dryer SE. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis. Neuroscience 2006 143 : 655 9
15. Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G. Clinical comparison of anti-MuSK vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 2007 68 : 609 11
16. Romi F, Aarli JA, Gilhus NE. seronegative myasthenia Seronegative gravis: disease severity and prognosis. Eur J Neurol 2005 12 : 413 18
17. Jaretski III, Bahron RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000 55 : 16 23
18. Dubowitz V. Muscle Biopsy, A Practical Approach, 2nd edn. London : Bailliere Tindall, 1985 612 15.
19. Pesce V, Cormio A, Fracasso F, Vecchiet J, Felzani G, Lezza AMS, Cantatore P, Gadaleta MV. Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscles. Free Rad Biol Med 2001 30 : 1223 33
20. Lexell J, Downham D, Sjostrom M. Morphological detection of neurogenic muscles disorders: how can statistical methods aid diagnosis? Acta Neuropathol 1987 75 : 109 15
21. Angelini C. Miastenia gravis. In Progressi Clinici in Medicina. Padova : Piccin, 1994 Vol. 2 n. 1, 209 220.
22. Rostedt Punga A, Ahlqvist K, Bartoccioni E, Scuderi F, Marino M, Suomalainen A, Kalimo H, Staelberg EV. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 2006 117 : 1434 43
23. Drachman DB. Myasthenia gravis. N Engl J Med 1994 330 : 1797 810
24. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004 29 : 484 505
25. Appel SH, Anwyl R, McAdams MW, Elias S. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proc Natl Acad Sci USA 1977 74 : 2124 30
26. Mossman S, Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1986 1 : 116 19
27. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003 60 : 1978 80
28. Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-jones D, Matthews PM, Vincent A. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 2006 129 : 1481 92
29. Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand 2006 114 : 124 32